Lupin supplies the second largest amount of generic drugs to the U.S. From October to December of last year, the U.S. market made up 49.4 percent of Lupin’s sales.
While President Donald Trump’s proposed border adjustment tax aims to encourage more manufacturing in the U.S. by implementing a tariff on imported goods, Mr. Gupta said the tax could adversely affect supply chains and cause higher costs for Indian drugmakers importing generic drugs into the U.S.
The drugmaker plans to launch 25 new products in the U.S. in fiscal year 2018.
More articles on supply chain:
Why pharmacists can’t speak up when they know customers are overpaying for drugs
LCMC Health partners with The Resource Group for supply chain services
Pharma leaders, healthcare experts advocate value-based payments for drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
